Omalizumab restores the ability of human plasmacytoid dendritic cells to induce Foxp3+Tregs
| dc.contributor.author | López Abente, Jacobo | |
| dc.contributor.author | Benito Villalvilla, Cristina | |
| dc.contributor.author | Jaumont, Xavier | |
| dc.contributor.author | Pfister, Pascal | |
| dc.contributor.author | Tassinari, Paolo | |
| dc.contributor.author | Palomares Gracia, Óscar | |
| dc.date.accessioned | 2024-01-25T10:12:43Z | |
| dc.date.available | 2024-01-25T10:12:43Z | |
| dc.date.issued | 2021 | |
| dc.description.abstract | IgE-FcεR1 cross-linking on human pDCs impairs their capacity to generate regulatory T-cells and in vitro omalizumab restores this ability. These findings may pave the way for novel biomarkers to assess omalizumab clinical efficacy and responder patients. | |
| dc.description.department | Depto. de Bioquímica y Biología Molecular | |
| dc.description.faculty | Fac. de Ciencias Químicas | |
| dc.description.refereed | TRUE | |
| dc.description.sponsorship | Ministerio de Ciencia, Innovación y Universidades (España) | |
| dc.description.sponsorship | Novartis | |
| dc.description.sponsorship | Ministerio de Economía y Competitividad (España) | |
| dc.description.status | pub | |
| dc.identifier.citation | López-Abente J, Benito-Villalvilla C, Jaumont X, Pfister P, Tassinari P, Palomares O. Omalizumab restores the ability of human plasmacytoid dendritic cells to induce Foxp3+Tregs. Eur Respir J. 2021 Jan 14;57(1):2000751. doi: 10.1183/13993003.00751-2020 | |
| dc.identifier.doi | 10.1183/13993003.00751-2020 | |
| dc.identifier.issn | 0903-1936 | |
| dc.identifier.officialurl | https://doi.org/10.1183/13993003.00751-2020 | |
| dc.identifier.relatedurl | https://pubmed.ncbi.nlm.nih.gov/32675208/ | |
| dc.identifier.uri | https://hdl.handle.net/20.500.14352/95318 | |
| dc.issue.number | 1 | |
| dc.journal.title | European Respiratory Journal | |
| dc.language.iso | eng | |
| dc.publisher | European Respiratory Society | |
| dc.relation.projectID | SAF-2017-84978-R | |
| dc.rights | Attribution 4.0 International | en |
| dc.rights.accessRights | restricted access | |
| dc.rights.uri | http://creativecommons.org/licenses/by/4.0/ | |
| dc.subject.cdu | 577.1 | |
| dc.subject.keyword | Omalizumab | |
| dc.subject.keyword | IgE | |
| dc.subject.keyword | Plasmacytoid dendritic cells | |
| dc.subject.keyword | Regulatory T cells | |
| dc.subject.ucm | Bioquímica (Medicina) | |
| dc.subject.ucm | Bioquímica (Química) | |
| dc.subject.ucm | Inmunología | |
| dc.subject.unesco | 2403 Bioquímica | |
| dc.subject.unesco | 2302 Bioquímica | |
| dc.subject.unesco | 2412 Inmunología | |
| dc.subject.unesco | 3207.01 Alergias | |
| dc.title | Omalizumab restores the ability of human plasmacytoid dendritic cells to induce Foxp3+Tregs | |
| dc.type | journal article | |
| dc.type.hasVersion | VoR | |
| dc.volume.number | 57 | |
| dspace.entity.type | Publication | |
| relation.isAuthorOfPublication | 3356f6c6-c499-44de-8faf-0e69c97d0167 | |
| relation.isAuthorOfPublication | 849d1c21-090b-4cfa-8f5b-857c7276b26d | |
| relation.isAuthorOfPublication.latestForDiscovery | 3356f6c6-c499-44de-8faf-0e69c97d0167 |
Download
Original bundle
1 - 1 of 1

